- Visibility 317 Views
- Downloads 48 Downloads
- Permissions
- DOI 10.18231/j.ijpp.2022.027
-
CrossMark
- Citation
An overview on prophylactic antibiotics in operative patients to combat post-surgical complications
Abstract
Antibiotics are the class of medications intended to treat and prevent bacterial infections by predominantly acting on bacteria by either making it difficult for the organism to grow and multiply or by killing them. They play a significant role in modern healthcare in improving patient health outcomes by reducing infective complications. In the emerging use of antibiotics, the pre and post-antibiotic regimen has a huge role in reducing the post-surgical complication which thereby increases the quality of life in surgical patients. Due to the irrational use of antibiotics, there is a rapid increase in the resistance to antimicrobial agents. Therefore, the rational operative antibiotic usage depends upon the factors like skin incision time; duration and frequency of administration; immunological status of the patient. Thus the importance of operative prophylaxis antibiotics has been discussed as a part of preventing surgical complications such as surgical site infections (SSI), antimicrobial resistance, septicaemia and adverse events during the patient's stay. This review is focused on the importance of prophylactic antibiotics, especially on major clean or clean-contaminated open surgeries which include cardiac surgery, gastro surgery and neurosurgery.
Introduction
Antibiotics are the class of medications intended to treat and prevent bacterial infections by predominantly acting on bacteria by either making it difficult for the organism to grow and multiply or by killing them.[1] They play a major role in the recent modern healthcare in improving the patient's health outcomes mainly in the areas of medicine or surgery, chronic conditions, Diabetes mellitus, end-stage renal disease, rheumatoid arthritis, organ transplants, or cardiac surgeries.[2] The antimicrobial agents are classed based on their pharmacology and in vitro effects into 2 major brackets: bactericidal and bacteriostatic. The bacteriostatic drugs ''kill'' the bacterial growth, has an MBC to MIC ratio of more than 4, and the bacteriostatic drugs that "retards the growth", have an MBC to MIC ratio less than or equal to 4. Further, to accurately group each category, criteria such as minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) must be clearly known. The minimum inhibitory concentration can be defined as the lowest concentration of an antimicrobial that shows a visible inhibition of bacterial growth within 24 hours. And, minimum bactericidal concentration is the concentration of the agent that causes a 1000-fold reduction of bacterial density within 24 hours.[3], [4] In surgical procedures, a prophylactic antibiotic indicates an antimicrobial agent that is administered in patients who have no established infections, which is further beneficial in preventing surgical site infections and other infections.[5] Prophylactic antibiotics should be administered intravenously to patients undergoing surgery. But, the choice of antibiotic, dose, and frequency of the regimen need further clarity. An efficient regimen can be beneficial in improving the health status of the patient which further reduces the economic burden on the patient.[6], [7]
The main aim of this literature review is to provide information on the importance of prophylaxis in different surgical departments, the timing of prophylaxis, incision time after administration, and the recent trends that are practised in surgery.
Appropriate Prophylactic Antibiotic Selection
The correct choice of the prophylactic agent is crucial in achieving the desired therapeutic outcome. In various animal studies and scientifically controlled clinical studies, the importance of prophylaxis against postoperative complications has been elucidated.[8] Certain standard measures have to be noted in selecting the right antibiotic therapy which include: The anatomic site of the surgery. The spectrum of activity of the antimicrobial; and the pharmacokinetic parameters. Some criteria have to be also taken into consideration with the above ones which include: resistance to the drug, possible interaction of the drug with other drugs, toxicity, and economic factors. Due to the irrational use of antibiotics, there is a rapid increase in the resistance to antimicrobial agents. In recent times, the use of broad-spectrum beta-lactam agents for surgical prophylaxis is not commended. The appropriate choice of Antibiotic prophylaxis is also dependent on multi-drug resistance, allergic reaction and the rate of infection. Clean contaminated surgical procedures and prosthesis insertion are the classic reasons for antibiotic prophylaxis. The NRC (National Research Council) has devised a 4-classification system which describes wounds. It is classified as clean, clean-contaminated, contaminated and dirty. For each of the above classes of the wound, the infection rates respectively are; <2%, 5-15%, and >30%.[9], [10] The main basis of this classification was the density of bacteria in the wound. Certain other factors that could be associated with an increased degree of post-operative infection include; weight reduction, depletion of protein, physiological dysfunction of an organ system, and overall poor health of the subject.[11] The increased mortality in patients undergoing surgery is associated with inappropriate or delayed antibiotic treatment. Therefore, the intravenous antibiotic regimen should have a broad-spectrum activity that covers all the likely infectious pathogens.[12] Generally for serious infections and major surgeries, potent antibiotics are not preferred to be used. To achieve the effective and maximum level of the drug in the serum and tissues during and after the incision, the maximum concentration of the prophylactic antibiotic should be administered preoperatively.[13], [14]
Timing and Duration of Prophylactic Antibiotic
The timing of the antibiotic for surgical patients plays a major role in better treatment outcomes. The timing of antibiotic administration was classified into four categories[15] and is depicted ([Table 1]). In the studies performed it was found that there was a considerable reduction in the incidences of surgical site infections when the prophylaxis was administered within 2 hours before surgery[16] whereas to avoid the chances of intra-operative contamination, it was found that an effective tissue concentration should be maintained which is achieved by administering the prophylactic antibiotics 30 mins prior the skin incision.[17] It should be noted that when the antibiotic is administered postoperatively in the recovery room, it might not show to be effective due to a combination of factors that prevent antibiotic delivery. These factors include vasoconstriction, thrombosis, and separation of wounds from the vascular systems which causes an inflammatory response. Effective serum tissue levels will not be achieved at lower levels. The majority of antibiotics administered as prophylaxis have a half-life of fewer than 2 hours, continuing the antibiotic regimen beyond the day of operation is neither beneficial nor reduces the risk of developing postoperative infections.[18], [19] In some cases the frequency of dosing is 2-4 hours intraoperatively even when the blood loss exceeds 1000ml.[18] Various studies have assessed the optimal duration of antibiotic prophylaxis peri operatively and suggested short term perioperative antibiotic regimen is as effective as long-term in the prevention of postoperative complications.[20] However long-term prophylaxis in certain cases can induce bacterial resistance that could vary from an individual patient and affect the clinical outcome.[21]
Administration time |
Category |
2 - 4 hours before skin incision |
Early prophylaxis |
2 hours before skin incision |
preoperative prophylaxis |
3 hours after skin incision |
peri-operative prophylaxis |
3 - < 24 hours after skin incision |
post operative prophylaxis |
Areas of Concern
Surgical site infection
Surgical site infections are the infections that develop and persist within 30 days of a surgical procedure in cases where there is no placement of an implant and within one year in cases of insertion of an implant.[22] They are the most frequently seen major serious post-operative complication seen in surgical patients. In a survey performed by TG Emori et al, according to the National Nosocomial Infections Surveillance (NNIS) system, it was reported that SSIs account for 12-16% of the major nosocomial infections among hospitalized patients.[23] SSI can have further effects on the patient and healthcare like increased antibiotic prescribing rate, and economic burden on the patients like laboratory costs. The patients who were found to have an infection rate of 60% were more likely to be admitted to the ICU, 5% more likely to be readmitted, they had a 2% higher mortality rate as compared to the non-infected people. Another interesting fact is that 40-60% of these infections are well preventable.[24] In a study performed by HH Stone et al; on antibiotic prophylaxis, it was concluded that the administration of antibiotics within 2 hours of any surgery had the lowest occurrence of surgical wound infection which was further supported by the logistic regression analysis. SSI can be considered as the index of the health care system in any hospital. It can be concluded that the time of antibiotic administration is inversely proportional to the incidences of wound infection.[25] The major organisms causing these include gram-positive cocci predominantly staphylococci, even though gram-negative bacteria are also involved. Therefore, when compliance with the antibiotic policies is followed, an overall improvement in the rate of patient wound infection can be seen.[26]
Adverse Drug Reaction
Whenever an exogenous product is administered into the body, it has a potential for developing an adverse reaction and antibiotics also have a similar property.[27] Every 5 patients in a hospital who are on antibiotics have been shown to develop such reactions. A survey on adverse events from the National Electronic Injury Surveillance System concluded that a major population of emergency department visits were due to an adverse reaction due to an antibiotic.[28] An adverse event should be clear foreseen when initiating any therapy, especially antibiotic therapy. The most susceptible population include paediatrics, geriatrics, immunocompromised patients, patients with other co-morbidities and hospitalized patients.[29] Therefore, it is very crucial to monitor if the patient uses higher class antibiotics and check the compliance with the standard policies of patients on antibiotic regimen especially on the prophylactic and empirical antibiotics in surgical patients for better therapeutic outcomes.[30]
Antimicrobial Resistance
A major area that requires attention due to the misuse and overuse of antibiotics when not under physicians' vigilance is antibiotic resistance. Due to the emergence and dissemination of resistance by bacterial pathogens, the efficacy of antibiotics has been altered. Certain pathogens such as Staphylococcus Aureus, Enterococcus spp., Pseudomonas aeruginosa along with some gram-negative become to all available antibiotics therapy. This leads to totally drug-resistant phenotypes causing an "antibiotic resistance crisis".[31] Bacteria have a short growth cycle and evolve very rapidly in the environment, which enables them to live through harsh and unfavourable conditions.[32] For many decades Methicillin-resistant S. aureus (MRSA), has been a major pathogen causing an antibiotic crisis which has a major effect on the clinical outcomes versus the methicillin-susceptible S. aureus.[32], [33], [34] MRSA has the highest prevalence in Asia among all the other continents.[35], [36] Generally, a higher MIC value above the susceptibility threshold can be concluded as antibiotic resistance. The resistance that occurs can have either intrinsic or acquired properties. All the available antibiotic classes of medications cannot act on all the various bacterial pathogens. Intrinsic resistance is termed when the bacteria do not have the target regions for antibiotic activity.[37] In cases where the pathogen acquires resistance from the genes of other bacteria or due to gene mutation, it leads to reduced antibiotic efficacy, which can be termed acquired resistance.[37] Vancomycin, a glycopeptide antibiotic which is often a drug of choice in treating the infections associated with MRSA for the last 7 years, shows that there is an increase in the incidence of vancomycin-intermediate S. aureus (VISA) and Vancomycin-resistant S. aureus (VRSA).[38] The inappropriate antibiotic prescribing pattern is a major contributing factor in the emergence of resistance.[10] Studies have also shown that in 30% and 50% of the cases, there is an inappropriate choice of an antibiotic, or false treatment indication.[39] The misuse and overuse of antibiotics lead to the development of resistance to all the antibiotic treatment modalities that cause the development of multi-drug resistant strains called "super-bugs".[40] These above factors influence the emergence of antimicrobial resistance which is a growing public health issue and requires appropriate awareness to promote the rational use of antibiotics.
Septicemia
Sepsis is one of the most dangerous post-operative complications observed. When an adequate antimicrobial prophylaxis has been administered, there is a lower rate of mortality among patients with gram-negative bacteraemia and other rate of infections.[41], [42], [43] Sepsis is defined as, the aggravated, inappropriate immune systemic immune response to the infection which is associated with organ dysfunction, hypoperfusion or hypotension.[44] This further creates a drastic burden on the healthcare system and economic burden. In a survey performed by Martin et al it was found that the number of sepsis related cases are increasing.[45] As per reports, this post operative infection still remains the leading cause of death in the U.S and one in three persons with sepsis are due to Surgical procedures.[46] The occurrence of sepsis is dependent on many factors which includes race, age, size of the hospital and the economic status of the patient. Furthermore, the evaluation of the surgical procedure, the patient population may help the associated complication.[47] The biochemical studies and genetic markers help in better diagnosis which may further prevent chances of mortality.[48] An appropriate antibiotic prophylaxis treatment is an important determinant of survival. Thus, an inappropriate antibiotic treatment was associated with increased mortality where, the efficiency of the therapy is independent of the rate of survival in comparison with immunomodulatory properties.[40]
Prophylaxis in Cardiac Surgery
As a routine practice, prophylactic antibiotics are generally administered to patients undergoing any type of cardiac surgical procedure.[48] But, the preferred choice of drug, dosage and frequency of the operative regimen is still under discussion. There is much evident morbidity, mortality and economic burden on the patient when nosocomial infections persist after surgery.[49] Hence, there are standard clinical practice guidelines that have been created that give the data on the choice of drug, duration, dose, frequency and therapy in case of predicted sepsis. The majority of the studies have shown that after the wound closure, the surgical prophylaxis is not needed and when single-dose studies were compared with double-dose antibiotic regimens, they did not show any further efficiency.[50] However, in recent times the guidelines have shown the importance of an elaborated prophylactic regimen in case of cardiac surgery like cardiopulmonary bypass, invasive devices after surgery, bleeding requiring blood transfusion and delayed extubation after a procedure. There are no sufficient data available on the pharmacokinetic parameters of antibiotics in cardiopulmonary bypass hence it is generally administered based on experience and historical practice.[51] Cardiac surgery has an increased chance of showing a high rate of systemic inflammatory response. The degree of this inflammatory response in an individual patient, and sometimes can be very harmful to the patient[52] In cardiothoracic surgery, it is recommended that all patients should be given prophylaxis and the antibiotics class of choice is first-or second-generation cephalosporin (cefazolin or cefuroxime)[53] Macrolides such as Clindamycin is used in cases of allergy to beta-lactams and vancomycin is used in cases of infection with methicillin-resistant staphylococcus aureus. The duration of the prophylaxis given should not be more than 48 hours; the skin incision should be done within 0.5 to 2 hours of the procedure. However, this timing can vary with the standard policies of other countries.[54] With regards to the choice of the antimicrobial agent, second-generation cephalosporins are more preferred compared to the other class of antibiotics, because they exhibit broad-spectrum activity and act on both the gram-negative and gram-positive pathogens. Further, they have a good safety with comparatively lesser side effects and can also be given to patients with penicillin allergies. But, the use of cephalosporins with Clostridium difficile infection is not well pronounced.[55] Recent studies have shown that there is an increasing trend in prescribing second-generation cephalosporins in cardiac surgeries due to their safety and efficacy profile.[56], [57]
Prophylaxis In Gastroenterology Surgery
The prophylactic antibiotics in the case of gastroenterology are based on criteria such as the type of gastrointestinal infection, the non-classic gastrointestinal disease that does not involve an infectious agent, and prophylaxis for gastrointestinal procedures. There are variety of classes of antibiotics, hence the appropriate selection of the antibiotics is focused on here.[58] In the case of Bacterial Diarrhoea, the main focus of treatment is rehydration and other non-pharmacological management. Antibiotic treatment is recommended in case of shigellosis, cholera, and Clostridium difficile diarrhoea. Among the newer generation of antibiotics, fluoroquinolones have a broader spectrum of activity except Clostridium difficile.[59] with the increase in the incidence of antibiotic resistance to drugs such as ampicillin and trimethoprim-sulfamethoxazole, quinolones have become the most preferred class of antibiotic in the management of diarrhoea. This is also associated with the management of Salmonella typhi infections. [60], [61] In case of relapsing Clostridium difficile infections, vancomycin in combination with rifampin is recommended.[62] There is not much-documented data on the infections due to endoscopy. But fatal infections have been reported after surgical procedures[63] While administering the antibiotics, certain criteria such as the nature of the organism, and the efficacy of the antibiotic administered should be taken into consideration. Other host factors that could also possibly increase the chance of infection include any cardio-vascular abnormalities, presence of prosthetic devices and immunocompromised state.[64], [65] The recent practices for the prophylaxis are based on extrapolations from various data on the risk of bacteraemia[66] The major indications for antibiotic prophylaxis, include bacterial endocarditis, cholangitis or sepsis due to (ERCP) Endoscopic retrograde cholangiopancreatography and wound infections with PEG. The administration of prophylaxis is also recommended in procedures involving immunocompromised patients undergoing bone marrow transplantation and patients with the presence of neutropenia.[67], [68]
Prophylaxis In Neurosurgery
The administration of a prophylactic antibiotic is the standard clinical practice before any neurosurgery. As per clinical studies, important criteria that should be taken into consideration include, the patient’s immune system, the nature of the pathological organisms and the nature of surgery. Intravenous first and second generation of cephalosporins are most commonly used and in case of allergy, vancomycin is recommended.[69] In a survey performed by Mazda KT et al. on the prophylactic use of antibiotics in neurosurgery, it was found that a single dose of antibiotic was used for about 85% of the cranial surgeries. It was also found that, cephalosporins (alone or in combination) from different generations was about 89.8%, 97% in cranial surgeries.[70] When many parameters like cost of the therapy, economic status of the patient, drug toxicological parameters, and the duration of the antibiotic therapy cefazolin is generally recommended in case of clean neurological surgery.[71]
Prophylaxis In Obstetrics and Gynaecology
SSIs are one of the most common complications associated with patients undergoing surgery. In gynaecological surgical patients it has a prevalence of 8-10% and the rate of infection varies from every individual patient depending on condition of the patient as well as surgical factors[72], [73] Generally in case of obstetric or gynaecological surgeries, multiple doses of the antibiotic is not recommended apart from the initial dose of the drug which includes the anaesthetic regimen. Further, studies performed on multiple doses of the antibiotic show no differences compared to the single dose of the drug.[74], [75] Preferably, the prophylactic antibiotic administered should be narrow spectrum in order to avoid chances of resistance.[76] Before every surgical procedure, it is very important to consider the source of pathogens. For majority of the obstetrics or gynaecological procedures, the source of pathogens is endogenous in nature present in the vagina or skin. The flora of the genital tract in women is polymicrobial, presence of anaerobes, gram-negative aerobes and gram-positive cocci. Further, in comparison with laparoscopic procedures where there is no mucosal surface and more chances of skin contamination only. While administering the antibiotic, the drug administered need not cover all the nature of the pathogens. Narrow spectrum cephalosporins are used more often in contrast to the second and third generation antibiotics because they have shown more incidences of antibiotic resistance and have less activity against Staphylococci.[77] The women undergoing C-section surgeries have more risk of developing infection compared to the women delivering vaginally.[78] Recent studies have shown that women undergoing C-Section surgery should be adequately administered with a surgical prophylaxis. A single dose of the antibiotic is generally administered within 30 minutes before the surgery.[79] The prevalence of infection in the first trimester of pregnancy is from 0.01 to 2.44% and there is a similar rate of prevalence in the second trimester also,[80], [81] Both oral doxycycline and metronidazole is beneficial in reducing the risk of post-abortal infection,[82] In procedures such as hysterectomy, it has been well established that for both vaginal and abdominal hysterectomy, the antibiotic prophylaxis benefits reduce post-operative infection.[83], [84] When a randomised non-blinded controlled trial was performed on women with bacterial vaginosis, it was seen that there was a significant reduction in the rate of vaginal cuff infection in post-hysterectomy patient on treatment with rectal metronidazole.[85] But, for certain low risk obstetrics and gynaecological procedures, such as laparoscopy, IUD or medical termination of pregnancy (MTP) does not require the administration of antibiotics.
Conclusion
In conclusion, it was found that surgical prophylaxis administered prior to surgery improves the treatment outcomes which is beneficial in the prevention of post-surgical complications. Further, the selection of the appropriate antibiotic is based on the cost, and the pharmacokinetic parameters including half-life, toxicity parameters, antimicrobial resistance, effectiveness and safety profile. In the case of major surgeries like cardiac surgery, gastric surgery, vascular surgery, obstetrics and gynaecological surgeries, the prophylaxis should be given 30-60 minutes before the incision time. However, the prophylactic antibiotic should be given 2 hours prior in case of neurosurgery and the antibiotic chosen should have a longer half-life in order to maintain the tissue levels during the entire procedure. Cephalosporins which are a broad-spectrum class of antibiotics are the most preferred class of drugs in major surgeries due to their bioavailability, half-life and safety parameters. Moreover, resistance to antimicrobials because of irrational use of antibiotics is an area of concern in recent times and adequate measures should be taken to reduce the unnecessary overuse and limit the spread of resistance. From this review, it was found that when suitable prophylaxis was administered there is a significant reduction in the rate of surgical site infections as well as other post-surgical complications. Thus, the prophylactic antibiotic administration long with appropriate post-operative care has proved a potent role in uneventful surgeries.
Abbreviations
SSI – Surgical Site Infection; MBC - Minimum Bactericidal Concentration; MIC – Minimum Inhibitory Concentration; NRC – National Research Council; NNIS – National nosocomial Infections Surveillance; ICU – Intensive Care Unit; MRSA – Methicillin Resistant Staphylococcus aureus; VISA – Vancomycin Intermediate Staphylococcus aureus; VRSA – Vancomycin Resistant Staphylococcus aureus; ERCP – Endoscopic Retrograde Cholangiopancreatography; PEG – Percutaneous Endoscopic Gastrostomy; IUD – Intrauterine Device; MTP – Medical Termination Of Pregnancy.
Source of Funding
None.
Conflict of Interest
None.
References
- Calhoun C, Wermuth H, Hall G. Antibiotics. Online] Ncbi.nlm.nih.gov. Available. 2022. [Google Scholar]
- Gould IM, Bal AM. New antibiotic agents in the pipeline and how they can help overcome microbial resistance.. Virulence. 2013;4(2):185-91. [Google Scholar]
- Pankey GA, Sabath LD. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections.. Clin Infect Dis. 2004;38(6):864-70. [Google Scholar]
- Rhee KY, Gardiner DF. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin Infect Dis. 2004;38(6):755-61. [Google Scholar]
- Ludwig KA, Carlson MA, Condon RE. Prophylactic antibiotics in surgery. . Annual Rev Med. 1993;44:385-93. [Google Scholar]
- Lola I, Levidiotou S, Petrou A, Arnaoutoglou H, Apostolakis E, Papadopoulos GS. . Are there independent predisposing factors for postoperative infections following open heart surgery? Journal of cardiothoracic surgery. 2011;6:1-9. [Google Scholar]
- Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR. . The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part I: duration. The Annals of thoracic surgery. 2006;81:397-404. [Google Scholar]
- Polk HC, Lopez-Mayor JF. Postoperative wound infection: a prospective study of determinant factors and prevention. Surgery. 1969;66(1):97-103. [Google Scholar]
- Page CP, Bohnen JM, Fletcher JR, Mcmanus AT, Solomkin JS, Wittmann DH. Antimicrobial prophylaxis for surgical wounds: guidelines for clinical care.. Arch Surg. 1993;128(1):79-88. [Google Scholar]
- . Office of Infectious Disease Antibiotic resistance threats in the United States. . 2013. [Google Scholar]
- Nichols RL. Surgical wound infection. Am J Med. 1991;91(3):54-64. [Google Scholar]
- Lador A, Nasir H, Mansur N, Sharoni E, Biderman P, Leibovici L. Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysis. J Antimicrob Chemother. 2012;67(3):541-50. [Google Scholar]
- Ludwig KA, Carlson MA, Condon RE. Prophylactic Antibiotics In Surgery. Ann Rev Med. 1993;44:385-93. [Google Scholar]
- Burdon DW. Principles of antimicrobial prophylaxis. World J Surg. 1982;6(3):262-9. [Google Scholar]
- Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. New England J Med. 1992;326(5):281-7. [Google Scholar]
- Shapiro M, Townsend TR, Rosner B, Kass EH. Use of antimicrobial drugs in general hospitals: patterns of prophylaxis. New England J Med. 1979;301(7):351-6. [Google Scholar]
- Condon RE, Wittmann DH. The use of antibiotics in general surgery. Current Problems Surg. 1991;28(1):807-907. [Google Scholar]
- Alexander DP, Becker JM. Cefoxitin disposition in colorectal surgery. Implications for the effective use of prophylactic antibiotics.. Annals Surg. 1988;208(1):162-8. [Google Scholar]
- Stone HH, Haney BB, Kolb LD, Geheber CE, Hooper CA. Prophylactic and preventive antibiotic therapy: timing, duration and economics. . Ann Surg. 1979;189(6):691-8. [Google Scholar]
- Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;15(1):1706-21. [Google Scholar]
- Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R. Preventing surgical-site infections in nasal carriers of staphylococcus aureus. New England J Med. 2010;362(1):9-17. [Google Scholar]
- Kumar A, Rai A. Prevalence of surgical site infection in general surgery in a tertiary care centre in India. Int Surg J. 2017;4(9):3101-7. [Google Scholar]
- Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory.. Clin Microbiol Rev. 1993;6(4):428-70. [Google Scholar]
- Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Hospital Infection Control Practices Advisory Committee. . Guideline for prevention of surgical site infection. 1999. [Google Scholar]
- Stone HH, Hooper CA, Kolb LD, Geheber CE, Dawkins EJ. Antibiotic prophylaxis in gastric, biliary and colonic surgery.. Ann Surg. 1976;184. [Google Scholar]
- Kirby JP, Mazuski JE. Prevention of surgical site infection.. Surg Clin North Am. 2009;89(2):365-89. [Google Scholar]
- Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Internal Med. 2017;177(9):1308-23. [Google Scholar]
- Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events.. Clinical Infect Dis. 2008;47(6):735-78. [Google Scholar]
- Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Int Med. 2017;177(9):1308-23. [Google Scholar]
- Lynch TJ. Choosing optimal antimicrobial therapies.. Med Clin. 2012;96(6):1079-94. [Google Scholar]
- Rossolini GM, Arena F, Pecile P, Pollini S. Update on the antibiotic resistance crisis.. Curr Opin Pharm. 2014;18:56-60. [Google Scholar]
- . World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report. . 2021. [Google Scholar]
- Hanberger H, Walther S, Leone M, Barie PS, Rello J, Lipman J. Increased mortality associated with meticillin-resistant Staphylococcus aureus (MRSA) infection in the Intensive Care Unit: results from the EPIC II study. Int J Antimicrob Agents. 2011;38(4):331-6. [Google Scholar]
- Weist K, Högberg LD. ECDC publishes 2015 surveillance data on antimicrobial resistance and antimicrobial consumption in Europe. Eurosurveillance. 2016;21(46). [Google Scholar]
- Hal SJV, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis. 2012;54(6):755-71. [Google Scholar]
- Chuang YY, Huang YC. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia. . Lancet Infect Dis. 2013;13:698-708. [Google Scholar]
- Chen LF, Chopra T, Kaye K;, Chen LF, Chopra T, Kaye KS. Pathogens resistant to antibacterial agents. Med Clin. 2011;95(4):647-76. [Google Scholar]
- Tiwari HK, Sen MR. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.. BMC Infect Dis. 2006;6:1-6. [Google Scholar]
- Luyt CE, Bréchot N, Trouillet JL, Chastre J. Antibiotic stewardship in the intensive care unit. Critical care. 2014;18(5):1-2. [Google Scholar]
- Alpert PT. Superbugs: antibiotic resistance is becoming a major public health concern.. Home Health Care Manag Pract. 2017;29(1):130-3. [Google Scholar]
- Weinstein MP, Towns ML, Quartey SM. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24(4):584-602. [Google Scholar]
- Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000;31(4):131-8. [Google Scholar]
- Niederman MS. Appropriate use of antimicrobial agents: challenges and strategies for improvement. Crit Care Med. 2003;31(2):608-16. [Google Scholar]
- Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644-89. [Google Scholar]
- Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through. New England J Med. 2000;17(16):1546-54. [Google Scholar]
- Anderson RN, Smith BL. Deaths: leading causes for 2002. National vital statistics reports. . 2005. [Google Scholar]
- Vogel TR, Dombrovskiy VY, Carson JL, Graham AM, Lowry SF. Postoperative sepsis in the United States. . Ann Surg. 2010;252(6):1065-71. [Google Scholar]
- Gorski A, Hamouda K, Özkur M, Leistner M, Sommer SP, Leyh R. Cardiac surgery antibiotic prophylaxis and calculated empiric antibiotic therapy.. Asian Cardiovascular Thoracic Ann. 2015;23(1):282-90. [Google Scholar]
- Reinhart K, Brunkhorst FM, Bone HE, Bardutzky J, Dempfle CE, Forst H. Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI). Der Anaesthesist. 2010;59(4):347-70. [Google Scholar]
- Torres SIB, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR. Centers for disease control and prevention guideline for the prevention of surgical site infection. JAMA Surg. 2017;152(8):784-91. [Google Scholar]
- Kappeler R, Gillham M, Brown NM. Antibiotic prophylaxis for cardiac surgery. J Antimicrobial chemother. 2012;67(3):521-3. [Google Scholar]
- Raja SG, Dreyfus GD. Modulation of systemic inflammatory response after cardiac surgery. . Asian Cardiovascular Thoracic Ann. 2005;13(4):382-95. [Google Scholar]
- Zhou L, Ma J, Gao J, Chen S, Bao J. Optimizing prophylactic antibiotic practice for cardiothoracic surgery by pharmacists’ effects. Medicine. 2016;95(9):777-80. [Google Scholar]
- Kato Y, Shime N, Hashimoto S, Nomura M, Okayama Y, Yamagishi M. Effects of controlled perioperative antimicrobial prophylaxis on infectious outcomes in pediatric cardiac surgery.. Crit care Med. 2007;35(1):1763-71. [Google Scholar]
- Gupta A, Hote MP, Choudhury M, Kapil A, Bisoi AK. Comparison of 48 h and 72 h of prophylactic antibiotic therapy in adult cardiac surgery: a randomized double blind controlled trial. J Antimicrob Chemother. 2010;65(5):1036-77. [Google Scholar]
- Nooyen S, Overbeek BP, Rivière AB. Prospective Randomised Comparison of Single-Dose versus Multiple-Dose Cefuroxime for Prophylaxis in Coronary Artery Bypass Grafting. Eur J Clin Microbiol Infect Dis. 1994;8(6):1033-70. [Google Scholar]
- Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Grauls CMV, Roosendaal R. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. New England J Med. 2010;362(1):9-17. [Google Scholar]
- Li E, Stanley JR. The role of newer antibiotics in gastroenterology. Gastroenterol Clin North Am. 1992;21(3):613-42. [Google Scholar]
- Gorbach S. Bacterial diarrhoea and its treatment.. Lancet. 1987;330(6):1378-82. [Google Scholar]
- Ferreccio C, Morris G, Valdivieso J, Prenzel C, Sotomayor I, Drusano V. Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers.. J infect Dis. 1988;157(1):1235-44. [Google Scholar]
- Gotuzzo E, Guerra JG, Benavente L, Palomino JC, Carrillo C, Lopera J. Use of norfloxacin to treat chronic typhoid carriers. J Infect Dis. 1988;157(6):1221-6. [Google Scholar]
- Tedesco FJ, Gordon D, Fortson WC. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroent. 1985;80(11):807-18. [Google Scholar]
- Axon AT, Cotton PB. Endoscopy and infection. Gut. 1983;24(11). [Google Scholar]
- Bianco JA, Pepe MS, Higano C, Appelbaum FR, Mcdonald GB, Singer JW. Prevalence of clinically relevant bacteremia after upper gastrointestinal endoscopy in bone marrow transplant recipients.. Am J Med. 1990;89:134-40. [Google Scholar]
- Tam F, Chow H, Prindiville T, Cornish D, Haulk T, Trudeau W. Bacterial peritonitis following esophageal injection sclerotherapy for variceal hemorrhage. Gastrointestinal Endoscopy. 1990;36(2):131-4. [Google Scholar]
- Neu HC, Fleischer D. Antibiotic prophylaxis for GI endoscopy. Am J gastroenterol. 1989;84(1):1488-91. [Google Scholar]
- Bianco JA, Pepe MS, Higano C, Appelbaum FR, Mcdonald GB, Singer JW. Prevalence of clinically relevant bacteremia after upper gastrointestinal endoscopy in bone marrow transplant recipients.. Am J Med. 1990;81(1):134-40. [Google Scholar]
- Neu HC, Fleischer D. antibiotic prophylaxis before endoscopy. The American journal of gastroenterology. . 1989;84(1):1488-91. [Google Scholar]
- Lusins JO, Nakagawa H. Rationale for prophylactic antibiotics in neurosurgery. Neurosurgery. 1981;9(2):142-142. [Google Scholar]
- Turel MK, Meshram B, Rajshekhar V. Survey of Prophylactic use of Antibiotics among Indian Neurosurgeons. Neurology India. 2021;69(6). [Google Scholar]
- Dempsey R, Rapp RP, Young B, Johnston S, Tibbs P. Prophylactic parenteral antibiotics in clean neurosurgical procedures: a review. J Neurosurg. 1988;69(1):52-9. [Google Scholar]
- Armstrong C. ACOG Releases Guidelines on Antibiotic Prophylaxis for Gynecologic Procedures. Am Fam Physician. 2007;75(7). [Google Scholar]
- Kamat AA, Brancazio L, Gibson M. Wound infection in gynecologic surgery. Infect Dis obstetrics Gynecol. 2000;8(5-6):230-4. [Google Scholar]
- Mcdonald M, Grabsch E, Marshall C, Forbes A. SINGLE-VERSUS MULTIPLE-DOSE antimicrobial prophylaxis for major surgery: a systematic review. Aust New Zealand J Surg. 1998;68(6):388-95. [Google Scholar]
- Mcgregor JA, French JI, Makowski E. Single-dose cefotetan versus multidose cefoxitin for prophylaxis in cesarean section in high-risk patients. Am J Obstet Gynecol. 1986;154(4):955-60. [Google Scholar]
- Weinstein JW, Roe M, Towns M, Sanders L, Thorpe JJ, Corey GR. Resistant Enterococci: A Prospective, Study of Prevalence, Incidence, and Factors Associated With Colonization in a University Hospital. Infect Control Hospital Epidemiol. 1996;17(1):36-41. [Google Scholar]
- Jones RN, Wojeski W, Bakke J, Porter C, Searles M. Antibiotic prophylaxis of 1,036 patients undergoing elective surgical procedures. A prospective, randomized comparative trial of cefazolin, cefoxitin, and cefotaxime in a prepaid medical practice. Am J Surg. 1987;153(4):341-6. [Google Scholar]
- Declercq E, Barger M, Cabral HJ, Evans SR, Kotelchuck M, Simon C. Maternal outcomes associated with planned primary cesarean births compared with planned vaginal births. Obstet Gynecol. 2007;109(3):669-77. [Google Scholar]
- Clifford V, Daley A. Antibiotic prophylaxis in obstetric and gynaecological procedures: a review. Australian New Zealand J Obstet Gynaecol. 2012;52(5):412-21. [Google Scholar]
- Achilles SL, Reeves MF. Prevention of infection after induced abortion. Contraception. 2011;83(4):295-309. [Google Scholar]
- Jacot FR, Poulin C, Bilodeau AP, Morin M, Moreau S, Gendron F. A five-year experience with second-trimester induced abortions: no increase in complication rate as compared to the first trimester. Am J obstet gynecol. 1993;168(2):633-40. [Google Scholar]
- Levallois P, Rioux JE. Prophylactic antibiotics for suction curettage abortion: results of a clinical controlled trial. . Am J obstet Gynecol. 1988;158(1):100-5. [Google Scholar]
- Duff P, Park RC. Antibiotic prophylaxis in vaginal hysterectomy: a review. Obstet Gynecol. 1980;55(5):193-202. [Google Scholar]
- Tanos V, Rojansky N. Prophylactic antibiotics in abdominal hysterectomy. J Am Coll Surg. 1994;179(5):593-600. [Google Scholar]
- Sarlos D, Kots L, Stevanovic N, Felten SV, Schär G. Robotic compared with conventional laparoscopic hysterectomy: a randomized controlled trial. Obstet Gynecol. 2012;120(3):604-15. [Google Scholar]
- Abstract
- Introduction
- Appropriate Prophylactic Antibiotic Selection
- Timing and Duration of Prophylactic Antibiotic
- Areas of Concern
- Adverse Drug Reaction
- Antimicrobial Resistance
- Septicemia
- Prophylaxis in Cardiac Surgery
- Prophylaxis In Gastroenterology Surgery
- Prophylaxis In Neurosurgery
- Prophylaxis In Obstetrics and Gynaecology
- Conclusion
- Abbreviations
- Source of Funding
- Conflict of Interest
- References
How to Cite This Article
Vancouver
S MAZ, John SA, M S, Chandy V. An overview on prophylactic antibiotics in operative patients to combat post-surgical complications [Internet]. Indian J Pharm Pharmacol. 2022 [cited 2025 Sep 25];9(3):150-157. Available from: https://doi.org/10.18231/j.ijpp.2022.027
APA
S, M. A. Z., John, S. A., M, S., Chandy, V. (2022). An overview on prophylactic antibiotics in operative patients to combat post-surgical complications. Indian J Pharm Pharmacol, 9(3), 150-157. https://doi.org/10.18231/j.ijpp.2022.027
MLA
S, Mohamed Aamir Zuhaib, John, Sneha Ann, M, Sunitha, Chandy, Vineet. "An overview on prophylactic antibiotics in operative patients to combat post-surgical complications." Indian J Pharm Pharmacol, vol. 9, no. 3, 2022, pp. 150-157. https://doi.org/10.18231/j.ijpp.2022.027
Chicago
S, M. A. Z., John, S. A., M, S., Chandy, V.. "An overview on prophylactic antibiotics in operative patients to combat post-surgical complications." Indian J Pharm Pharmacol 9, no. 3 (2022): 150-157. https://doi.org/10.18231/j.ijpp.2022.027